nogapendekin alfa inbakicept-pmln
Anktiva Approved for BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
The FDA approved nogapendekin Anktiva with Bacillus Calmette-Guérin for adult patients with BCG-unresponsive ...
APRIL 24, 2024

Load more